Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
Public ClinicalTrials.gov record NCT00107939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Licarbazepine 750 ¿ 2000 mg/d as Adjunctive Therapy to an Atypical Antipsychotic in the Treatment of Manic Episodes of Bipolar I Disorder Over 6 Weeks
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the effectiveness and tolerability of an investigational drug for the treatment of manic episodes of bipolar disorder. The investigational drug will be given as additional therapy to one of the five following medications: risperidone, olanzapine, quetiapine, ziprasidone, or aripiprazole. These medications are already FDA (Food and Drug Administration)-approved treatments for mania.
Study identification
- NCT ID
- NCT00107939
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 453 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2004 (Type not available)
- Primary completion
- Apr 2007 (Actual)
- Completion
- Apr 2007 (Actual)
- Last update posted
- Mar 22, 2017
2004 – 2007
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Little Rock | Arkansas | 72201 | — |
| Investigational Site | Orange | California | 92868 | — |
| Investigational Site | Pico Rivera | California | 90660 | — |
| Investigational Site | San Diego | California | 92108 | — |
| Investigational Site | San Diego | California | 92126 | — |
| Investigational Site | Boca Raton | Florida | 33432 | — |
| Investigational Site | Atlanta | Georgia | 30308 | — |
| Investigational Site | Chicago | Illinois | 60640 | — |
| Investigational Site | Joliet | Illinois | 60435 | — |
| Investigational Site | Indianapolis | Indiana | 46222 | — |
| Investigational Site | Topeka | Kansas | 66606 | — |
| Investigational Site | Kansas City | Missouri | 64133 | — |
| Investigational Site | St Louis | Missouri | 63104 | — |
| Invetigational Site | Brooklyne | New York | 11201 | — |
| Investigational Site | Cedarhurst | New York | 11516 | — |
| Investigational Site | New York | New York | 10003 | — |
| Investigational Site | Cincinnati | Ohio | 45267 | — |
| Investigational Site | Columbus | Ohio | 43210 | — |
| Investigational Site | Providence | Rhode Island | 02903 | — |
| Investigational Site | Bellaire | Texas | 77401 | — |
| Investigational Site | Bellevue | Washington | 98004 | — |
| Investigational Site | West Allis | Wisconsin | 53227 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00107939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 22, 2017 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00107939 live on ClinicalTrials.gov.